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Background: Along with research on development of more efficient gene delivery systems, it is necessary to
search on stabilization processes to extend their active life span. Chitosan is a nontoxic, biocompatible and available
gene delivery carrier. The aim of this study was to assess the ability of this polymer to preserve transfection
efficiency during spray-drying and a modified freeze-drying process in the presence of commonly used excipients.
Methods: Molecular weight of chitosan was reduced by a chemical reaction and achieved low molecular weight
chitosan (LMWC) was complexed with pDNA. Obtained nanocomplex suspensions were diluted by solutions of
lactose and leucine, and these formulations were spray dried or freeze dried using a modified technique. Size,
polydispersity index, zeta potential, intensity of supercoiled DNA band on gel electrophoresis, and transfection
efficiency of reconstituted nanocomplexes were compared with freshly prepared ones.
Results and conclusion: Size distribution profiles of both freeze dried, and 13 out of 16 spray-dried
nanocomplexes remained identical to freshly prepared ones. LMWC protected up to 100% of supercoiled structure
of pDNA in both processes, although DNA degradation was higher in spray-drying of the nanocomplexes prepared
with low N/P ratios. Both techniques preserved transfection efficiency similarly even in lower N/P ratios, where
supercoiled DNA content of spray dried formulations was lower than freeze-dried ones. Leucine did not show a
significant effect on properties of the processed nanocomplexes. It can be concluded that LMWC can protect DNA
structure and transfection efficiency in both processes even in the presence of leucine.
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While viral gene delivery systems are more efficient and
targeted than non-viral gene delivery systems in transdu-
cing cells, there are serious concerns about their safety
[1]. In addition, they have limited capacity for DNA
packing and are not easy to produce. These major short-
comings have become a motive force for research on
safe and efficient non-viral gene delivery systems. Poly-
mers have received more attention because their ease of
production and modification can be applied to overcome
major defects of non-viral gene delivery systems such as
low transfection, targeting efficiency and toxicity [2].* Correspondence: gilani@sina.tums.ac.ir.
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reproduction in any medium, provided the orAlongside efforts to make more safe and efficient gene
carriers, it is necessary to make them stable during stor-
age. Stability of non-viral gene delivery systems has been
a major concern since the first days of gene therapy clin-
ical trials [3]. Presence of water can alter the stability of
non-viral gene delivery systems in short term storage by
facilitating their aggregation [4] and in long term by in-
creasing the likelihood of water catalyzed chemical reac-
tions, which may alter the stability of nucleic acids [5].
On the other hand, low efficiency of non-viral gene de-
livery systems calls for application of high doses of DNA
in a limited volume in-vivo, which cannot be achieved
during preparation of polymeric gene delivery systems.
Because polyplexes aggregate in high concentrations [6].
Removing water from polyplex suspensions, results in
pharmaceutically reasonable stability profile at room
temperature and simultaneously increases concentration
of therapeutic gene in the formulation. These formulationsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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or reconstituted with water before application.
In solid state, polymer based gene delivery systems
have an advantage over lipid based ones because they
are less vulnerable to oxidative reactions [7]. Although
freeze-drying is a well-established industrial approach,
conventional freeze-drying can exacerbate aggregation in
its freezing step by concentrating nanosuspension in un-
frozen phase. Therefore, special modifications have been
considered to increase cooling rate to overcome this de-
fect [8]. On the other hand, it has been shown that
spray-drying of insulin loaded chitosan/tripolyphosphate
nanoparticles did not change their size and zeta poten-
tial significantly [9]. This was attributed to the high dry-
ing speed [10]. However, it has been reported that
excessive shear rate can destroy supercoiled structure of
plasmid [11]. Appropriate design of a gene delivery sys-
tem is of critical importance not only for protecting nu-
cleic acids in-vivo but also for preserving them against
the process stresses like temperature and shear.
The ability of a lipid-protein gene delivery system to
protect DNA in a spray-drying process and the effects of
various excipients on transfection efficiency and aero-
dynamic properties of the resulted powder had been
thoroughly studied by Li et al. [12,13]. In vivo gene
transfer performance of a chitosan-pDNA complex pro-
cessed by supercritical technology have been studied by
Okamuto et al. [14]. Regarding DNA stability in super-
critical fluid technology, the main destabilizing factor is
dissolved carbon dioxide in water, which builds up an
acidic pH and promotes DNA hydrolysis, while in spray-
drying, the shear stress and temperature are main
destabilizers.
Availability, biocompatibility, inherent positive charge
and permeability enhancing capability make chitosan an at-
tractive non-viral gene delivery system [15]. Polyion com-
plex associates of chitosan and DNA are strong and have
been suggested to be further stabilized by hydrogen and
hydrophobic bonds. It has also been hypothesized that
these bonds are strong enough to prevent DNA liberation
from complexes and thus decrease free plasmid content
after endosomal escape and detract from transfection effi-
ciency of the polymer [16]. Molecular weight reduction has
been applied as a successful strategy to increase the trans-
fection efficiency of chitosan, with a suggested mechanism
of loosening the bond between DNA and the polymer [17].
So, Chitosan can be applied as a good representative to
study protection of plasmid DNA by polymeric gene deliv-
ery systems against the process stresses.
The aim of this study was to evaluate the ability of low
molecular weight chitosan to protect bioactivity of
pDNA against shear and thermal stresses generated dur-
ing spray-drying and high freezing rate freeze-drying




Medium viscose chitosan was obtained from Primex
(Siglufjordur, Iceland). Sodium nitrite, sodium hydroxide,
glacial acetic acid and L-leucine were purchased from
Merck KGaA (Frankfurt, Germany). Lactose monohydrate
free sample was provided by DMV-Fonterra Excipients
(Foxhol, Netherlands). All cell culture materials were
obtained from Invitrogen (CA, USA).
Amplification of plasmid
pEGFP-N1 plasmid (Clontech Laboratories, CA, USA)
encoding the enhanced green fluorescent protein as a
reporter was amplified in Escherichia coli DH5α by over-
night incubation of the bacteria and then purification of the
plasmid by a Giga plasmid purification kit (Nucleobond™
PC 10000, Macherey-Nagel GmbH & CO. KG, Düren,
Germany). The resulted plasmid was analyzed for its purity
and concentration by gel electrophoresis and UV absorp-
tion at 260 and 280 nm (Picodrop™, Saffron Walden, UK).
Preparation of low molecular weight chitosan (LMWC)
Low molecular weight chitosan was prepared by chemical
reaction between chitosan and nitrous acid. Two grams of
medium viscose chitosan (Primexehf, Siglufjordur, Iceland)
slowly dispersed into 78 ml deionized water. Then, 6 ml
glassial acetic acid was added to the dispersion to dissolve
chitosan. Nitrogen bubbled into this solution and then
16 ml of a freshly prepared sodium nitrite solution with a
concentration of 5 mg/ml was added. Reaction mixture
was sealed by a cap and stirred in room temperature for 90
minutes then pH was adjusted to 9 by adding 4 M sodium
hydroxide to terminate the reaction. The resulting suspen-
sion was centrifuged at 6000 rpm, and the sediment was
washed by ice-cold water thoroughly over a buchner fun-
nel, redissolved in a minimum amount of 1% acetic acid
solution and dialyzed against two liters of deionized water,
which was replaced every 12 hours, for 48 hours. The
resulted solution was freeze-dried, and the powder was
kept at 2-8°C in the dark until use.
Molecular weight (Mw, Mn) and polydispersity (Mw/
Mn) of LMWC were determined by gel permeation
chromatography. The polymer dissolved at the concen-
tration of 0.1% in 0.3 M acetate buffer with a pH value
of 4.6. The resulted solution filtered through a 0.22 μ fil-
ter and chromatographed at 25°C using the same eluent
at a flow rate of 4 ml/min through a PL aquagel-OH
Mixed –H 25 mm ID 8 μm column on a Knuer chroma-
tographic system (Knuer, Berlin, Germany), which was
equipped with an intrinsic viscosity detector. Pullulan
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bration using the same conditions.
Particle formation
To prepare a stock solution of LMWC, the polymer was
dissolved in 0.005 M acetate buffer with a pH value of 5
and its concentration was adjusted to 7 mg/ml, then this
solution was centrifuged at 30000 Relative Centrifugal
Force (RCF) for 60 minutes in 4°C (Sigma Laborzentrifugen
GmbH, Osterode, Germany) and the supernatant was
filtered through a 0.22 μ filter. This solution was stored at
2-8°C in the dark and used within a week from the date of
preparation.
Nanocomplexes of LMWC and pEGFP-N1 were pre-
pared using the ionic gelation method. For preparation of
each nanocomplex formulation predetermined volumes of
LMWC stock solution were diluted with the same solvent
to obtain target concentration and was added to the same
volume of pDNA solution with concentration of 40 ng/μl,
which was prepared in Milli-Q water, in three increments
at room temperature and under the vortex. After addition
of LMWC to pDNA solution, the mixture was incubated
in room temperature for 20 minutes for the particle for-
mation before further experiments.
Spray-drying
Nanocomplex formulations spray dried immediately after
formation (Buchi B-191 mini-spray dryerTM; Buchi
Labortechnik AG, Switzerland) to make powder formula-
tions given in Table 1. The spray-drying conditions were
the same as reported by Li et al. [13], which were: inlet
temperature 150°C, spray flow rate 600 liter/h, aspirator
adjusted to 35 m3/h, pump adjusted to 30% to give a flow
rate of 7.5 ml/min. These conditions resulted in an outlet
temperature of 70-85°C. The spray-drying yield was calcu-
lated, and the recovered powders stored in moist resistant
containers at 2-8°C until next experiments.
Freeze-drying
Nanocomplex formulations were freeze-dried immediately
after preparation by a modified freeze-drying technique.
Briefly, prepared nanosuspensions were transferred to
cryotubes and immersed in liquid nitrogen for 10 minutes
to snap freeze the nanosuspensions, then these tubes wereTable 1 Theoretical composition of freeze dried and spray dr
Formula
Components 100 L 100 N 70 L 70 N 50 L 50 N 20 L
DNA 0.5 0.5 0.5 0.5 0.5 0.5 0.5
LMWC 33.7 33.7 23.6 23.6 16.8 16.8 6.7
Lactose 2000 2000 2000 2000 2000 2000 2000
Leucine - 200 - 200 - 200 -
All measurements are in milligrams.transferred to a pre-cooled freeze-dryer chamber (Alpha
1-4 LD plusTM, Martin Christ Gefriertrocknungsanlagen
GmbH, Osterode, Germany) after loosening their caps.
Freeze-drying conditions were: 48 h in 0.04 mbar to give
an ice condenser temperature of -50°C and 12 h in
0.001 mbar for ice condenser temperature of -80°C.
Particle size and zeta potential analyses
Particle size and zeta potential of the nanocomplexes
were measured before and after freeze or spray-drying by
a Zetasizer Nano ZS™ (Malvern Instruments, Malvern,
Worcestershire, UK). Freshly prepared nanocomplexes
and dry powders were diluted in Milli-Q water to give a
count rate of 100-200 KC/S. All measurements were per-
formed at 25°C in triplicate. Viscosity and refractive index
of water in this temperature (0.8905 mPa s, 1.333) were
used for data analysis.
Stability of pDNA
To analyze the integrity of DNA after spray and freeze-
drying, plasmid DNA was electrophoresed after dissoci-
ation from LMWC. To dissociate DNA, an amount of
each nanocomplex formulation equivalent to 1.5 μg of
DNA was dispersed in 30 μl water. This suspension was
added to 1.5 mg of heparin, which was dissolved in the
same volume of water and incubated for five hours at
room temperature. After the incubation time, 20 μl of
the resulted suspension was mixed with 4 μl of loading
dye and was loaded into each well of a 0.5% agarose gel,
which were stained with EtBr, and electrophoresed at a
voltage of 100 V, in TBE buffer (pH 8) for 60 minutes.
Gel images were acquired by a BioDoc-ItTM imaging
system (UVP, Upland, CA, USA), while uncomplexed
pDNA was used as control. The acquired images were
processed to reduce EtBr background fluorescence and
analyzed by Image J software (Rasband, W.S., ImageJ, U. S.
National Institutes of Health, Bethesda, Maryland, USA,
http://rsb.info.nih.gov/ij/, 1997-2009).
In-vitro transfections
The day before transfection, each well of a 24 well cell
culture plate, containing 1 ml of DMEM media supple-
mented with 10% FBS and 1% penicillin-streptomycin,
was seeded with 70000 low passage 293 T cells. Transfectionied powders
tions
20 N 10 L 10 N 7 L 7 N 5 L 5 N 2 L 2 N
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
6.7 3.4 3.4 2.36 2.36 1.68 1.68 0.67 0.67
2000 2000 2000 2000 2000 2000 2000 2000 2000
200 - 200 - 200 - 200 - 200
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transfection, the media was replaced with 500 μl of fresh
serum free media (at pH 6.9). After replacement of media
100 μl of nanocomplex formulation or reconstituted powder
(equal to 2 μg of pEGFP-N1) were transferred to each well.
Cells were incubated at 37°C, 5% CO2, with nanocomplexes
for 4 h and then the medium replaced by 1 ml of fresh
serum containing media.
Seventy-two hours later, cells were washed with warm
PBS buffer twice and trypsinized for 5 minutes. Then
500 μL PBS buffer, supplemented with 10% FBS was
added to neutralize trypsin and cells were analyzed by
flow cytometry (CyFlow™, Partec GmbH, Münster,
Germany) to assess GFP expression.
Statistical analysis
To compare particle size distribution curves two differ-
ent techniques were applied,(i.e. Kolmogorov-Smirnov
(K-S test) and similarity factor (f2)) K-S test was selected
as a non-parametric method to compare distribution
curves of the processed nanocomplexes by freshly pre-
pared ones. Similarity factors were calculated using the















In which Rj and Tj were the average intensity percent given
by the instrument for a particular size (j) and wj is a weight
factor for each size point, which here was set to be 1. These
tests were selected because in the case of particle size the
assumption for parametric tests (i.e. t-test) that sample is
normally distributed is not correct and these distribution
profiles are mostly right-skewed and bimodal, which can-
not be fully represented by mean and standard deviation.
To study the effect of process, addition of leucine and
N/P ratio on stability of pDNA and transfection effi-
ciency a three-way analysis of variance was used.
Results
Molecular weight
Chemical reaction with NaNO2 has been used before for
depolymerization of chitosan. The molecular weight of
the polymer was demonstrated to reduce linearly with
the ratio of chitosan/NaNO2 [18]. The molecular weight
of chitosan was determined by gel permeation chroma-
tography coupled with refractive index detector. The
number and weight molecular weight of LMWC were
9.8 kDa and 16 kDa respectively, which resulted in a
polydispersity index of 1.63.Size and zeta potential of nanoparticles
Size, polydispersity index (PdI) and zeta potential data of
the nanocomplex formulations before and after proces-
sing by spray-drying or freeze-drying are presented in
Figure 1. Reduction of N/P ratio increased the Z-average
particle size and polydispersity index and decreased the
zeta potential.
To determine success of the two processing techni-
ques in preservation of particle size of nanocomplexes,
Kolmogorov-Smirnov (K-S test) test, a nonparametric
statistical test, was used. Similarity factor was also used
to compare average particle size distribution curves of
the freshly prepared nanocomplex formulations with
processed ones. Results of these two tests are presented
in Tables 2 and 3. The p-Values for K-S test (Table 2),
showed that all formulations prepared by freeze-drying
and 13 out of 16 spray-dried formulations successfully
preserved the original size distribution profile of nano-
complexes over a broad range of N/P ratios. Results of
K-S test for particle size comparison were in consistent
with polydispersity data (Figure 1b). Calculated similarity
factors showed a reduction as N/P ratio decreased and the
statistical difference between formulations became signifi-
cant when the similarity factor was below 82.
The data indicated that the average zeta potential
decreased from around 30 for N/P equal to 100 and 70
to around 20 for N/P of 5 and 2.
Comparing the processed nanocomplexes with similar
N/P ratios, the K-S test did not show significant differ-
ences between particle size distribution curves of the
formulations prepared in presence or absence of leucine
(all p-values were above 0.05).Stability of pDNA
Stability of plasmid bounded with LMWC after freeze-
drying and spray-drying processes was determined by
electrophoresis. Figure 2a, shows images of two sample
gels and Figure 2b presents percent of preserved super-
coiled structure in the both processes. Nanocomplex for-
mulations prepared with N/P ratios of 2 and 5 showed
lowest stability of DNA during both processes, with
approximately 70 percent of the supercoiled pDNA
remaining intact.
A three-way ANOVA test used to study the effect of
process, addition of leucine and N/P ratio on supercoiled
structure stability. There was a significant difference
between the effect of freeze-drying and spray-drying
processes on preserving the supercoiled structure
(p <0.001). In addition, it was shown that the stability of
supercoiled structure was increased significantly with
the increase in N/P ratio (p < 0.001). The test did not
show a significant destabilization effect for leucine on
supercoiled structure (p= 0.184).
Figure 1 Size, polydispersity and zeta potential of freshly prepared and reconstituted nanocomplexes from freeze dried or spray dried
powders. a, z-average size, b, polydispersity index and c, zeta potential, Points are averages of three measurements and error bars are standard deviation.
Mohajel et al. DARU Journal of Pharmaceutical Sciences 2012, 20:22 Page 5 of 9
http://www.darujps.com/content/20/1/22In-vitro transfection
The relative transfection efficiency of the nanocomplexes
is presented in Figure 3. Except for N/P ratios of 2 and 5,
all N/P ratios in both kinds of processed powders couldretain approximately their original transfection efficiency.
Even spray dried powders showed 100% relative transfec-
tion, although their supercoiled pDNA content was lower
than the freeze-dried powders. To analyze the effect of the
Table 2 p-Values of K-S tests for comparison of size distribution profiles of processed nanocomplexes with freshly
prepared ones
Formulations
100 L 100 N 70 L 70 N 50 L 50 N 20 L 20 N 10 L 10 N 7 L 7 N 5 L 5 N 2 L 2 N
Freeze dried 0.860 0.508 0.822 0.713 0.943 0.877 0.84 0.806 0.205 0.08 0.109 0.518 0.681 0.448 0.244 0.595
Spray dried 0.84 0.777 0.240 0.38 0.748 0.174 0.799 0.79 0.115 0.167 0.799 0.343 0.392 0.02* 0.02* 0.045*
*statistically meaningful difference from original size distribution profile.
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three-way analysis of variance was conducted. The test did
not show a meaningful effect for the type of process or
addition of leucine (p=0.827and p=0.476, respectively),
while the effect of N/P ratio was reemphasized (p< 0.001).Discussion
Effects of three different variables (i.e. processing tech-
nique, N/P ratio and presence of leucine) on physico-
chemical and biological properties of nanocomplexes
were tested by statistical analysis. These effects have
been discussed below.Effect of N/P ratio
The decrease in the number of positively charged amine
groups with respect to negatively charged phosphate
groups led to a reduction in zeta potential and in turn,
made the nanocomplexes more vulnerable to aggregate.
It has been shown that chitosan-DNA nanocomplexes
aggregate quickly in Hank’s buffered salt solution at the
amine per phosphate ratio of 5 [19]. Increased aggrega-
tion rate in lower N/P ratios makes stabilization of the
nanocomplexes more challenging [20]. This effect can
be seen in the difference of particle size distribution of
three spray-dried formulations with lower N/P ratios
form freshly prepared ones.
According to our results N/P ratio had a significant ef-
fect on stability of supercoiled structure and preserva-
tion of biological activity during both tested processes. It
has also been demonstrated in previous researches that
increased N/P ratio can increase physical stability of
DNA containing nanocomplexes against shear stress
[21]. The level of protection also depends on the type of
complexing agent. Lipoplexes are shown to be more vul-
nerable against shear stress generated during nebuliza-
tion (27).Table 3 Calculated similarity factors between size distribution
with those of freshly prepared ones
Formula
100 L 100 N 70 L 70 N 50 L 50 N 20 L
Freeze dried 93.73 93.13 97.31 97.39 94.36 98.79 97.5
Spray dried 95.84 94.41 95.14 89.33 88.93 86.85 89.56Effect of processing technique
Kuo et al. [21] compared Z-average particle sizes of poly
(ethyleneimine)-pDNA polyplexes before and after a
spray-freeze-drying process and observed no statistically
meaningful difference between the two groups. However,
to our knowledge there are not more reports, comparing
size distribution of nanocomplexes prepared by pDNA
and a polymeric carrier before and after a drying process.
The high rate of aggregation of LMWC-pDNA nano-
complexes necessitates instant immobilization of the
system to prevent changes in particle size. Although
both techniques applied in this work have such a cap-
ability, but spray-drying of liquid formulations took
more time than freezing in liquid nitrogen to immobilize
the nanocomplexes. Therefore, it seemed that in low
N/P ratios, the rate of aggregation of the nanocomplexes
was higher than the rate of drying of the nanocomplexes
during the spray-drying process.
Stability of the supercoiled structure can also be
altered by processing technique. Seville et al. freeze
dried a lipid :polycation :pDNA vector with a similar
freeze-drying technique [11]. Their results showed 100%
stability of supercoiled DNA during the process. Mohri
et al., showed that chitosan can protect pDNA in N/P
ratios over 5 during a spray freeze-drying process [22]. It
was shown that a freeze drying process with increased
cooling rate can improve preservation of biological ac-
tivity of non-viral gene delivery systems [8], despite the
fact that rapid freezing of naked DNA can extensively
damage its structure [23,24]. Our results also indicated
that by applying a similar freeze-drying condition, in
N/P ratios > 10, a 100% preservation of supercoiled plas-
mid could be obtained.
On the other hand, spray-drying is known to be a
harsher technique compared to freeze-drying. Seville
et al. recovered 70-80% of original supercoil band
strength after processing of a lipid-protein carrier byprofiles of freeze dried and spray dried nanocomplexes
tions
20 N 10 L 10 N 7 L 7 N 5 L 5 N 2 L 2 N
99.35 90.96 87.32 88.48 83.19 87.49 86.15 93.67 90.31
90.38 85.62 83.79 94.25 93.35 86.57 81.24 74.41 81.61
Figure 2 a, Electrophoresis images of dissociated pDNA from reconstituted nanocomplexes processed by freeze-drying (upper) and
spray-drying (lower) pure pDNA was used as control. b, relative intensity of supercoiled pDNA band of freeze dried and spray dried
nanocomplexes. Error bars are standard deviation (n = 3).
Mohajel et al. DARU Journal of Pharmaceutical Sciences 2012, 20:22 Page 7 of 9
http://www.darujps.com/content/20/1/22spray-drying technique [13], but here we achieved over
90% of the band strength in N/P ratios of 10, 20 and 50
and even 100% at N/P ratios of 70 and 100.
While powders processed by spray-drying showed lower
stability profile in nanocomplex size and supercoiled DNA
content, compared to freeze-dried ones, their transfection
efficiencies were not significantly affected. Our data is in
accordance with Seville and coworkers, who has reported
an enhancement in transfection efficiency of spray dried
powders despite lower supercoiled DNA content com-
pared to freeze dried formulations. They did not compareFigure 3 Relative transfection efficiency of reconstituted freeze driedsize distribution of nanocomplexes before, and after pro-
cessing but our data showed an increase in polydispersity
of spray-dried formulations, which along with reduction
in content of supercoiled structure should have led to a
decrease in biological activity of the formulations. These
findings suggest even enhancement of transfection activity
in spray-drying or reduction of this ability in freeze-drying
via unknown mechanisms.
There are some reports indicating enhanced gene
expression after freeze-drying or spray-drying of gene
delivery systems. Seville et al. witnessed a 50% increase inor spray dried powders. Error bars are standard deviation (n = 3).
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technique but freeze-dried powders did not show the
same result [11]. Talsma et al. observed enhanced trans-
fection efficiency after freeze-drying of an adenovirus-
enhanced AVET system, but in the case of pCMVL:trans-
ferrin-poly(ethlenimine) complexes, they showed 100% of
original transfection efficiency after freeze-drying in a 10%
sucrose solution [25]. Furthermore, Kuo and Hwang did
not report an enhancement in transfection ability of poly
(ethyleneimine)-DNA complexes processed by spray-
freeze-drying [21]. In this work, we did not see a meaning-
ful increase in transfection efficiency after spay drying and
freeze-drying.
Effect of leucine
Leucine is a common excipient in the formulation of dry
powder inhalers to enhance dispersibility of the powders.
A previous report indicated that co-processing of a
lipid-polycation-pDNA with leucine and lactose led to
the reduction of the biological activity of the plasmid,
compared to those which formulated with just lactose in
transfecting A549 cells [26]. Therefore, it has been sug-
gested that leucine acts as a destabilizer for complex be-
tween DNA and a positively charged material. We added
leucine to our powder formulations to assess the ability
of chitosan in maintaining original size distribution,
DNA structure and transfection in the presence of this
excipient. Our results did not show a meaningful effect
for leucine on any of the mentioned indicators. This ef-
fect can be attributed to higher resistance of chitosan
bond with DNA against the effect of leucine. Köping-
Höggård and coworkers found that incubation with so-
dium chloride, 3.5 M, sodium dodecyl sulfate, 0.5 M or
heparin, with a 10-fold excess of negative charges could
not liberate DNA from its complex by ultrapure chito-
san. Based on these works higher stability of chitosan
nanocomplexes with plasmid is plausible.
Conclusion
In this work, we tried to assess the ability of LMWC as
a carrier to protect supercoiled structure and thus trans-
fection ability of plasmid DNA, and maintain the ori-
ginal size of the freshly formed nanocomplexes during
the harsh conditions of spray-drying and freeze-drying
processes. Our indicators were size, zeta potential, poly-
dispersity index, intensity of supercoiled bond on elec-
trophoresis gel and transfection efficiency in in-vitro
conditions.
LMWC could efficiently protect plasmid supercoiled
structure and retain its transfection capability against
stresses imposed by freeze-drying and spray-drying pro-
cesses. The stability of supercoiled structure was also
retained in the presence of leucine, which has been
reported to destabilize the complex between DNA and apositively charged material. Our finding suggests that
LMWC carrier is resistant to the drying process stresses
imposed to gene delivery systems.
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